Education & Training

The Dr. Stephen A. Harrison Patient Advocacy Fellowship offers a flexible, experience-based approach to learning, designed to equip patient advocates with a strong foundation in regulatory science and clinical trials literacy.

Throughout the Fellowship, participants engage with mentors, guest experts, and peers through virtual discussions, collaborative activities, and real-world advocacy experiences. The program provides exposure to key concepts and conversations that shape liver disease research, drug development, and policy.

Fellows explore topics such as the design and interpretation of clinical trials, regulatory pathways for new treatments, health technology assessment, and the critical role of the patient voice in shaping research priorities and healthcare decisions. Content is tailored to individual interests and advocacy goals, allowing Fellows to dive deeper into areas most relevant to their work.

Fellows will also participate in flagship face-to-face and online conferences on SLD research and diagnostics, and be introduced to key opinion leaders and companies in MASH drug development.

This evolving learning experience is designed to build confidence, foster connections, and empower advocates to engage meaningfully in scientific and policy conversations around steatotic liver disease.